|
|
| (52 intermediate revisions by 2 users not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT[[Anaplastic large cell lymphoma]] |
| {{SI}}
| |
| {{DiseaseDisorder infobox |
| |
| Name = auses
| |
| | |
| Anaplastic large cell lymphoma, ALK negative | |
| | |
| ls|
| |
| ICD10 = {{ICD10|C|84|4|c|81}} |
| |
| OMIM = |
| |
| MedlinePlus = |
| |
| eMedicineSubj = |
| |
| eMedicineTopic = |
| |
| }}
| |
| {{CMG}}; {{AE}} {{AP}}
| |
| | |
| {{SK}} ALCL-ALK(-); ALK-negative ALCL; ALK negative ALCL; ALK negative anaplastic large cell lymphoma
| |
| | |
| ==Overview==
| |
| The ALK negative anaplastic large cell lymphoma is a [[peripheral T-cell lymphoma]] [[Non-Hodgkin's lymphoma]]. ALK negative ALCL [[T-cell]]s express [[CD30]], but doesn't express the ALK ('''A'''naplastic '''L'''ymphoma '''K'''inase) chimeric protein.<ref name=Swerdlow>{{cite book | last = Swerdlow | first = Steven | title = WHO classification of tumours of haematopoietic and lymphoid tissues | publisher = International Agency for Research on Cancer | location = Lyon, France | year = 2008 | isbn = 9789283224310 }}</ref>
| |
| | |
| ==Classification==
| |
| ===Morphologic Classification===
| |
| | |
| ==Pathophysiology ==
| |
| | |
| ==Causes==
| |
| | |
| == Differential Diagnosis ==
| |
| | |
| == Epidemiology and Demographics==
| |
| | |
| ==Natural History, Complications and Prognosis==
| |
| | |
| ===Prognosis===
| |
| | |
| == Diagnosis ==
| |
| | |
| ===History and Symptoms===
| |
| | |
| ===Laboratory Findings===
| |
| | |
| == Treatment ==
| |
| | |
| ==References==
| |
| {{Reflist|2}}
| |